There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Matetzky, S,, et al,: Circulation, 109, 3171 (2004); Bassand, J,, et al,: Eur, Heart J,, 28, 1598 (2007); Jakubowski, J,, et al,: Cardiovasc, Drug Rev,, 25, 357 (2007)"
Synonyms
Ticagrelor EP Impurity A
Application Notes
"AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS)."
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Overview
"AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS)."
![Ethyl 2-[[(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]aceta](https://structures.clearsynth.com/CS-TB-42851.png)
![N-(2-(3,4-difluorophenyl)cyclo propyl)-N-(5-(propylthio)-3-((1R,2S,3S,4R)-2,3,4-trihydroxy cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)nitrous amide](https://structures.clearsynth.com/CS-O-47381.PNG)
